Giant Cell Glioblastoma, also known as monstrocellular sarcoma, is related to glioma susceptibility 1 and pleomorphic xanthoastrocytoma, and has symptoms including headache and seizures. An important gene associated with Giant Cell Glioblastoma is MSH2 (MutS Homolog 2), and among its related pathways/superpathways are Infectious disease and Apoptotic Pathways in Synovial Fibroblasts. The drugs Sargramostim and Molgramostim have been mentioned in the context of this disorder. Affiliated tissues include brain and eye, and related phenotypes are Decreased viability and Increased shRNA abundance (Z-score > 2)